Virtu KCG Holdings’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Virtu KCG Holdings’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$348K	Sell	3,471 -440	-11%	-$47.4K	0.01%	1501
2017 Q1	$473K	Buy	+3,911	New	+$480K	0.01%	1430
2016 Q4	–	Sell	-19,047	Closed	-$2.53M	–	3952
2016 Q3	$2.53M	Buy	19,047 +14,390	+309%	+$1.38M	0.06%	235
2016 Q2	$426K	Sell	4,657 -41,367	-90%	-$3.48M	0.01%	1522
2016 Q1	$3.32M	Buy	+46,024	New	+$2.52M	0.09%	131
2015 Q3	–	Sell	-8,266	Closed	-$1.01M	–	3988
2015 Q2	$1.01M	Buy	+8,266	New	+$938K	0.02%	827
2014 Q4	–	Sell	-3,016	Closed	-$244K	–	4374
2014 Q3	$244K	Sell	3,016 -10,425	-78%	-$922K	﹤0.01%	2636
2014 Q2	$1.44M	Buy	+13,441	New	+$935K	0.02%	806

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Virtu KCG Holdings's GWPH Position: Q2 2017 in Review

Virtu KCG Holdings reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 11% in Q2 2017, selling an estimated $47.4K and leaving 3,471 shares worth $348K. The position accounts for 0.01% of the portfolio, ranked #1501.

Virtu KCG Holdings first reported a position in GWPH in Q2 2014 and has held it in 8 quarters since. The position peaked at $3.32M in Q1 2016. 170 funds tracked by Wall St. Rank hold GWPH as of Q2 2017.

Virtu KCG Holdings held 3,471 shares of GW Pharmaceuticals Plc American Depositary Shares worth $348K as of Q2 2017.
Virtu KCG Holdings sold 440 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2017, an estimated $47.4K.
GW Pharmaceuticals Plc American Depositary Shares made up 0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #1501 holding.
Virtu KCG Holdings first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q2 2014 and has held it in 8 quarters since.
Virtu KCG Holdings's GW Pharmaceuticals Plc American Depositary Shares position peaked at $3.32M in Q1 2016.
170 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.